Management recommendations for kidney transplantation in patients with plasma cell dyscrasia

By afschroeder • July 31, 2025

Murakami N, Blosser CD, Webber AB, Gupta G, Singh N, Boppana S, Master S, Parasuraman R, Campagnaro EL, Java A, Sprangers B, Bhasin-Chhabra B, Lum E, Khirfan D, Alexander P, Molnar MZ, Benes B, Thakur AK, Bumma N, Karam S, Hultcrantz M, Bridoux F, Sanchorawala V, Leung N, Landau H. Management recommendations for kidney transplantation in patients with plasma cell dyscrasia. Kidney Int. 2025 Jul 28:S0085-2538(25)00576-9. doi: 10.1016/j.kint.2025.07.011. Epub ahead of print. PMID: 40738478.

Tags: AL amyloidosis, Kidney transplant, monoclonal gammopathy, Multiple myeloma, Nephrology, plasma cell dyscrasia, Publications

Related Posts

Intravitreal vascular endothelial growth factor inhibitor systemic and renal toxicity registry

Nguyen MD, Fekrat R, Gee C, Demirci AN, Kharabaf S, Le D, Tadros M, Nguyen VQ, Patel S, Truong T, Ahdoot R, Kurtz IB, Kerr[...]

Experiences and perspectives of patients and their caregivers on gastrointestinal symptoms in peritoneal dialysis: Workshop report

Hayat A, Johnson DW, Manera K, Viecelli AK, Wilkie M, Shen J, Wang AY, Htay H, Jaure A, Cho Y, Walker R. Experiences and perspectives[...]

Associations Between Donor-derived Cell-free DNA Dynamics and Clinical Outcomes After Kidney Allograft Rejection: A Prospective, Multi-center Study

Bunnapradist S, Leca N, Zaky ZS, Stratta RJ, Khamash HA, Shihab F, Ekwenna O, Aldana-Campos M, Kahwaji J, Biancone L, Maw TT, Biagini DG, Kaur[...]